What rapamycin is
Rapamycin (generic name sirolimus) is an approved drug that inhibits mTOR, a master regulator of cell growth, metabolism and cellular “self-cleaning” (autophagy). It is used clinically to prevent transplant rejection and in certain cancers and coronary stents.
Why it matters for longevity
Rapamycin is the most reproducible pharmacological life-extender in animal research: in the NIA Interventions Testing Program (ITP) it extended lifespan in genetically diverse mice across independent laboratories, even when started late in life. This mTOR pathway overlaps with the benefits attributed to caloric restriction.
What the evidence shows
Human evidence for *longevity* is still early. The PEARL trial (2025) found that intermittent low-dose rapamycin over a year was reasonably well tolerated in healthy adults, but it was not designed to prove an anti-ageing or mortality benefit. Off-label “longevity” use is therefore Emerging: strong mechanism and animal data, immunosuppression and metabolic side-effects to weigh, and no completed trial showing it extends healthy human lifespan.
What to ask a clinic
Off-label rapamycin should involve a clinician who reviews your history, discusses dosing schedules and side-effects (mouth ulcers, lipid and glucose changes, infection risk), and arranges monitoring. Be wary of anyone presenting it as a proven anti-ageing pill.